AccuMed teams with Xillix

17 Jun 2002

As part of the AccuMed (Chicago, IL) acquisition of a two-thirds equity interest in Oncometrics Imaging Corp., a wholly owned subsidiary of Xillix Technologies Corp. (Richmond, BC, Canada), AccuMed, and Xillix will jointly develop cancer- screening technology. Noting that Oncometrics will now have the resources to continue development of a diagnostic system for lung cancer, company president and CEO Branko Palcic says, "With AccuMed, we have the opportunity to commercially exploit our previous work in cervical cancer management especially in the US market."
Courtesy of Laser Focus World